This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
11-13 November 2025
Congress Center BaselBasel, Switzerland

Damian Ackermann, PhD
Principal Scientist at Novartis
Speaker

Profile

Damian Ackermann is a Senior Expert in Science & Technology at Novartis AG, specializing in process development within the Chemical and Analytical Development organization. He supports oligonucleotide projects from early to late clinical phase, leveraging over 25 years of experience in nucleic acid chemistry. He began his career with a PhD in RNA synthesis at ETH Zurich, followed by postdoctoral research at the University of Bern and the University of Bonn. He gained industrial experience at Microsynth AG before joining Novartis in 2021, where he has expanded his expertise in oligonucleotide therapeutics and large-scale manufacturing.

Agenda Sessions

  • Early and Late Phase Process Optimization of siRNA Manufacturing

    08:05